Small Molecular Metabolite Targets for Treatment of Rheumatoid Arthritis Previous research has shown that small molecular metabolites, like PGs, LTs, LXs, PAF, ROS, and NO, support to induce, maintain, or relieve inflammation in RA ( Table 2 )
Effects of incretin-based therapy on CV complications In line with previous evidence accrued in patients with T2D 83 , recent data demonstrated for the first time that incretin-based therapy was associated with CV risk reduction in patients with overweight or obesity with normoglycemia or prediabetes
& Wright, G
Inquire about licensing here
It also improves cognitive function, promoting better concentration and memory
In preclinical settings it is commonly used to explore fat-mobilisation pathways and weight-management concepts without the full growth hormone sequence